- INSTRUCTOR Medicine, Endocrinology, Diabetes and Bone Disease
American Board of Internal Medicine
MD, Albert Einstein College of Medicine
Residency, Internal Medicine
Cedars-Sinai Medical Center
Mount Sinai School of Medicine
Dara Cohen, a graduate of the Albert Einstein College of Medicine, completed her internship and residency at Cedars Sinai Medical Center in Los Angeles, CA. She returned to New York in 2009 to pursue a postdoctoral research fellowship and a clinical fellowship in Endocrinology, Diabetes and Metabolism at Mount Sinai. During her training, she was involved in several research projects focusing on the connection between diabetes and cancer.
Her clinical interests include Type 1 and Type 2 Diabetes, Gestational Diabetes, thyroid disease, adrenal disorders, bone diseases and female reproductive disorders.
Glasgow-Rubin Achievement Citation
American Medical Women's Association
Alpha Omega Alpha
Alpha Omega Alpha
Cohen D, LeRoith D. Obesity, Type 2 Diabetes & Cancer: The Insulin & Insulin-Like Growth Factor Connection. Endocrine Related Cancer (in press).;.
Cannata D, Kirschenbaum A, Levine A. Clinical Case Seminar: Androgen Deprivation Therapy as Primary Treatment for Prostate Cancer. JCEM 2012 February;: 360-5.
Ferguson R, Alikhani N, Vijayakumar A, Fierz Y, Cannata D, Yakar S. IGF-1 Cellular Action and its Relationship to Cancer: Evidence from in Vitro and in Vivo Studies. Springer Science+Business Media 2012;.
Elis S, Wu Y, Courtland H, Cannata D, Sun H, Beth-On M, Liu C, Jasper H, Domené H, Karabatas L, Guida C, Basta-Pljakic J, Cardoso L, Rosen C, Frystyk J, Yakar S. IGF1 enhances somatic growth. Dis Model Mech 2011 Sept-Oct;.
Lann D, Wu Y, Elis S, Yakar S, Cannata D, Lazzarino D, Wood T, LeRoith D. Elevated circulating IGF-I promotes mammary gland development and proliferation. Endocrinology 2010 December; 151(12): 5751-61.
Cannata D, Fierz Y, Vijayakumar A, LeRoith D. Type 2 diabetes and cancer: what is the connection? . Mt Sinai J Med 2010; 2(77): 197-213.
Cannata Y, Vijayakumar A, Fierz Y, LeRoith L. The GH/IGF-I axis in growth and development: New insights derived from animal models. Adv Pediatr 2010;: 331-51.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Cohen did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Atran Berg Laboratory Building Floor 4th Floor Room AB4-45
1428 Madison Avenue
New York, NY 10029
10 East 102nd Street
New York, NY 10029
- Monday 8:00am - 12:00pm
- Wednesday 8:00am - 12:00pm
- Friday 8:00am - 12:00pm
- 1199 Member Choice
- Blue Cross/ Blue Shield
- GHI Medicare
- HIP Commercial
- Oxford Freedom
- Oxford Liberty
- United Health Care - Mount Sinai Top Tier
- United Health Care Commercial
- United Health Care Empire Plan
- Master Card
- American Express
- Personal Check